BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 34687756)

  • 1. Pan-cancer analysis and experiments with cell lines reveal that the slightly elevated expression of DLGAP5 is involved in clear cell renal cell carcinoma progression.
    Feng Y; Li F; Yan J; Guo X; Wang F; Shi H; Du J; Zhang H; Gao Y; Li D; Yao Y; Hu W; Han J; Zhang M; Ding R; Wang X; Huang C; Zhang J
    Life Sci; 2021 Dec; 287():120056. PubMed ID: 34687756
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of cyclin F/CCNF as an independent prognostic factor for poor survival in clear cell renal cell carcinoma.
    Kwiatkowski M; Krajewski A; Durślewicz J; Buchholz K; Grzanka D; Gagat M; Zabrzyński J; Klimaszewska-Wiśniewska A
    Sci Rep; 2024 Apr; 14(1):9280. PubMed ID: 38654021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of BRAF-activated long non-coding RNA is associated with the proliferation of clear cell renal cell carcinoma.
    Xue S; Jiang SQ; Li QW; Wang S; Li J; Yang S; Zhang HM; Xu YF; Wang LS; Zheng JH
    BMC Urol; 2018 Sep; 18(1):79. PubMed ID: 30200918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low level of Cyclin-D1 correlates with worse prognosis of clear cell renal cell carcinoma patients.
    Wang QS; Li F; Liao ZQ; Li K; Yang XL; Lin YY; Zhao YL; Weng SY; Xia Y; Ye Y; Li SH; Wang CY; Lin Y
    Cancer Med; 2019 Aug; 8(9):4100-4109. PubMed ID: 31183974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phospholipase D2 promotes disease progression of renal cell carcinoma through the induction of angiogenin.
    Kandori S; Kojima T; Matsuoka T; Yoshino T; Sugiyama A; Nakamura E; Shimazui T; Funakoshi Y; Kanaho Y; Nishiyama H
    Cancer Sci; 2018 Jun; 109(6):1865-1875. PubMed ID: 29660846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Clinical and Cellular Impact of RBMS2 on the Progression and Prognosis of Kidney Renal Clear Cell Carcinoma.
    Gao Z; Fan S
    Genet Res (Camb); 2023; 2023():5512781. PubMed ID: 38058408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic analysis of RNASET2 gene as a potential prognostic and immunological biomarker in clear cell renal cell carcinoma.
    Liu Y; Zhang Z; Xi P; Chen R; Cheng X; Liu J; Zhu Q; Nie Y; Sun T; Gong B; Wang S
    BMC Cancer; 2023 Sep; 23(1):837. PubMed ID: 37679715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTX3 modulates the immunoflogosis in tumor microenvironment and is a prognostic factor for patients with clear cell renal cell carcinoma.
    Netti GS; Lucarelli G; Spadaccino F; Castellano G; Gigante M; Divella C; Rocchetti MT; Rascio F; Mancini V; Stallone G; Carrieri G; Gesualdo L; Battaglia M; Ranieri E
    Aging (Albany NY); 2020 Apr; 12(8):7585-7602. PubMed ID: 32345771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMPs-related risk model identification and SAA1 promotes clear cell renal cell carcinoma migration via ERK-AP1-MMPs axis.
    Wei H; Li Y; Zhang J; Xu C; Wei D; Quan C; Zhu S
    Sci Rep; 2024 Apr; 14(1):9411. PubMed ID: 38658579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SEMA3G functions as a novel prognostic biomarker associated with Wnt pathway in clear cell renal cell carcinoma.
    Wang H; Zhang W; Ding Z; Ke H; Su D; Wang Q; Xu K
    Cell Signal; 2023 Nov; 111():110868. PubMed ID: 37633476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying TYMP as an Immune Prognostic Marker in Clear Cell Renal Cell Carcinoma.
    Chen SA; Zhang JP; Wang N; Chen J
    Technol Cancer Res Treat; 2023; 22():15330338231194555. PubMed ID: 38043946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PPARγ is dispensable for clear cell renal cell carcinoma progression.
    Sanchez DJ; Steger DJ; Skuli N; Bansal A; Simon MC
    Mol Metab; 2018 Aug; 14():139-149. PubMed ID: 29866440
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of serine metabolism enzyme PSAT1 predicts poor prognosis and promotes proliferation, metastasis and drug resistance of clear cell renal cell carcinoma.
    Ye J; Huang X; Tian S; Wang J; Wang H; Feng H; Zhao X; Cao S; Xuan Y; Li X; Ma X; Huang Y; Zhang X
    Exp Cell Res; 2024 Apr; 437(1):113977. PubMed ID: 38373588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of inflammation and immune-related gene NOD2 in clear cell renal cell carcinoma.
    Lyu L; Min R; Zheng F; Xiang W; Huang T; Feng Y; Zhang C; Yuan J
    Hum Cell; 2024 May; 37(3):782-800. PubMed ID: 38509270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-Cell Transcriptome Analysis Reveals Intratumoral Heterogeneity in ccRCC, which Results in Different Clinical Outcomes.
    Hu J; Chen Z; Bao L; Zhou L; Hou Y; Liu L; Xiong M; Zhang Y; Wang B; Tao Z; Chen K
    Mol Ther; 2020 Jul; 28(7):1658-1672. PubMed ID: 32396851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of CHST11, a novel biomarker, on the biological functionalities of clear cell renal cell carcinoma.
    Hu W; Chen Y; Zhang L; Guo X; Wei X; Shao Y; Wang D; Wu B
    Sci Rep; 2024 Apr; 14(1):7704. PubMed ID: 38565604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathogenic Roles for RNASET2 in Clear Cell Renal Cell Carcinoma.
    Peak T; Tian Y; Patel A; Shaw T; Obermayer A; Laborde J; Kim Y; Johnson J; Stewart P; Fang B; Teer JK; Koomen J; Berglund A; Marchion D; Francis N; Echevarria PR; Dhillon J; Clark N; Chang A; Sexton W; Zemp L; Chahoud J; Wang L; Manley B
    Lab Invest; 2024 May; 104(5):102041. PubMed ID: 38431116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of NR3C1 inhibits the proliferation and migration of clear cell renal cell carcinoma through activating endoplasmic reticulum stress-mitophagy.
    Yan M; Wang J; Wang H; Zhou J; Qi H; Naji Y; Zhao L; Tang Y; Dai Y
    J Transl Med; 2023 Oct; 21(1):701. PubMed ID: 37807060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MOICS, a novel classier deciphering immune heterogeneity and aid precise management of clear cell renal cell carcinoma at multiomics level.
    Liu Y; Qi L; Ye B; Wang A; Lu J; Qu L; Luo P; Wang L; Jiang A
    Cancer Biol Ther; 2024 Dec; 25(1):2345977. PubMed ID: 38659199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lysine methyltransferase 5C increases the proliferation and metastatic abilities of clear cell renal cell carcinoma via aerobic glycolysis.
    Zeng B; Wan R; Chang K; Li J; Zhang X; Shi G; Ye D; Xu F
    Int J Oncol; 2024 Apr; 64(4):. PubMed ID: 38426605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.